Prediction of brain atrophy using three drug scores in neuroasymptomatic HIV-infected patients with controlled viremia
Open Access
- 1 September 2015
- journal article
- Published by Elsevier in The Brazilian Journal of Infectious Diseases
- Vol. 19 (5) , 503-509
Abstract
No abstract availableKeywords
Funding Information
- Provincial Secretariat for Science and Technological Development (114-451-2255/2011-01)
This publication has 48 references indexed in Scilit:
- Neurocognitive Function in HIV Infected Patients on Antiretroviral TherapyPLOS ONE, 2013
- HIV, Vascular and Aging Injuries in the Brain of Clinically Stable HIV-Infected Adults: A 1H MRS StudyPLOS ONE, 2013
- Neuronal Toxicity in HIV CNS DiseaseFuture Virology, 2012
- Independent Effects of HIV, Aging, and HAART on Brain Volumetric MeasuresJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?HIV Medicine, 2011
- Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohortAIDS, 2011
- Subcortical brain atrophy persists even in HAART-regulated HIV diseaseBrain Imaging and Behavior, 2011
- HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral TreatmentThe Journal of Infectious Diseases, 2010
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performanceAIDS, 2009
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous SystemArchives of Neurology, 2008